Shares in Hims Hers Health Inc (NYSE:HIMS) fell Friday after Citigroup (NYSE:C) analysts downgraded the stock to Sell/High Risk, citing overvaluation concerns tied to its GLP-1 revenue stream.

BlackRock has announced its departure from the Net Zero Asset Managers (NZAM) initiative following increasing pressure from ...

Italy's Prada is among the potential suitors looking at fashion group Versace, put up for sale by parent Capri Holdings, and ...

Wells Fargo & Company WFC is slated to report fourth-quarter 2024 results on Jan. 15, 2025, before market open. Among Wells ...